Kyle A. Romine

Integrative analysis of drug response and clinical outcome in acute myeloid leukemia

Daniel Bottomly, Nicola Long, Anna Reister Schultz et al. · Cancer Cell · 2022 · 368 citations · Full text

Medicine, Cancer Biology, Oncology +17

Monocytic Differentiation and AHR Signaling as Primary Nodes of BET Inhibitor Response in Acute Myeloid Leukemia

Kyle A. Romine, Tamilla Nechiporuk, Daniel Bottomly et al. · Blood Cancer Discovery · 2021 · 35 citations · Full text

Medicine, Cancer Biology, Oncology +14

Biomarkers Predicting Venetoclax Sensitivity and Strategies for Venetoclax Combination Treatment

Haijiao Zhang, Beth Wilmot, Daniel Bottomly et al. · Blood · 2018 · 33 citations

Medicine, Immunology, Pharmacology +4

BET inhibitors rescue anti-PD1 resistance by enhancing TCF7 accessibility in leukemia-derived terminally exhausted CD8+ T cells

Kyle A. Romine, Hyun-Jun Cho, Yoko Kosaka et al. · Leukemia · 2023 · 29 citations · Full text

Life Sciences, Immunology, Oncology +17

Acute myeloid leukemia–induced T-cell suppression can be reversed by inhibition of the MAPK pathway

Kaycee B. Moshofsky, Hyun J. Cho, Guanming Wu et al. · Blood Advances · 2019 · 18 citations · Full text

Life Sciences, Immunology, Oncology +17